Amylyx Pharmaceuticals, Inc. (AMLX)
14.01
-0.01
(-0.07%)
USD |
NASDAQ |
Feb 20, 16:00
14.01
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals SG&A Expense (Quarterly) : 16.17M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 682.50M |
| Cytokinetics, Inc. | 69.46M |
| Ionis Pharmaceuticals, Inc. | 96.81M |
| MediciNova, Inc. | 1.554M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |